X4 Pharmaceuticals, Inc
Company Stats
- Market Cap
- $287.5M
- as of Sep 30, 2026
- Shares Outstanding
- 99.1M
- Free Float
- 78.4%
Income Statement
- Revenue
- $35.1M
- Operating Income
- -$86.9M
- Net Income
- -$79.2M
- EBITDA
- -$85.6M
Cash Flow
- Free Cash Flow
- -$85.6M
- FCF Yield
- -29.8%
- Owner FCF Yield
- -31.3%
Balance Sheet
- Cash & Equivalents
- $217.0M
Returns & Capital
- SBC, 3Y Avg
- $7.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $35.1M | -$85.6M | -243.8% |
| FY2024 | $2.6M | -$131.2M | -5132.1% |
| FY2023 | $0 | -$96.6M | — |
| FY2022 | $0 | -$77.2M | — |
| FY2021 | $0 | -$71.5M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 12, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.